急性B型主动脉夹层合并灌注不良的预后预测因素
本研究回顾性分析了两家欧洲高容量主动脉中心2005年3月至2016年1月间因急性B型主动脉夹层合并灌注不良接受TEVAR治疗的41例患者,30天死亡率为17.1%,灌注不良综合征数量是30天灌注不良相关并发症或死亡的唯一独立预测因素。
要点
- 急性B型主动脉夹层合并灌注不良行TEVAR后30天死亡率为17.1%。
- 灌注不良综合征数量是30天灌注不良相关并发症或死亡的独立预测因素。
- 早期识别灌注不良相关并发症可能挽救生命,但仍缺乏硬性标准。
核心结论
- 急性B型主动脉夹层初始合并灌注不良综合征的患者预后严重,尤其是多区域缺血时。
- 早期识别这些并发症可能挽救生命,但仍缺乏硬性标准。
研究设计与样本
- 回顾性研究,纳入2005年3月至2016年1月两家欧洲高容量主动脉中心因急性(<14天)B型主动脉夹层合并灌注不良接受TEVAR的所有患者。
- 共纳入41例患者,年龄60岁(IQR 51-68.5),78%为男性。
主要发现
- 68.3%的患者仅有一种灌注不良综合征,肾缺血最常见(53.6%)。
- 主动脉覆盖中位长度为197 mm(IQR 157-209)。
- 17例患者(41%)在支架植入后对25个分支进行了额外的内脏/肾/髂动脉支架置入。
- 30天死亡率为17.1%,除2例早期死亡外均与灌注不良相关。
- 灌注不良综合征数量是30天灌注不良相关并发症或死亡的唯一独立因素(3 vs 1,HR=30.3,P=0.001;3 vs 2,HR=9.9,P=0.004)。
临床怎么用
- 对于急性B型主动脉夹层合并灌注不良的患者,应评估灌注不良综合征的数量以识别高危患者。
- TEVAR可用于改善主动脉分支血管血流,必要时可联合分支支架置入。
局限性
- 回顾性研究设计。
- 样本量较小(41例)。
- 仅纳入两家中心,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute type B aortic dissection (AoD) with malperfusion is a rare and complex disease. In this specific setting, invasive treatment is generally required to improve aortic branch vessel flow. Thoracic aorta stent grafting (TEVAR) of the proximal descending thoracic aorta to cover/exclude the proximal intimal entry tear would promote resolution of the dynamic component (the most prevalent) of the malperfusion conflict by redirecting the flow within the true lumen. The aim was to study outcomes of patients undergoing TEVAR for acute (<14 days) type B AoD complicated with malperfusion and to depict any preoperative and intraoperative predictors that could affect the prognosis of those patients. METHODS: From March 2005 to January 2016, all patients treated with TEVAR for acute type B AoD with malperfusion in 2 European high-volume aortic centers were retrospectively studied. Preoperative, intraoperative, and postoperative details were collected. Preoperative computed tomography angiogram was reanalyzed on a dedicated 3D workstation (Aquarius iNtuition Viewer, TeraRecon). Thirty-day malperfusion-related complication and mortality rates were determined. Logistic regression model was used to assess preoperative and intraoperative factors affecting postoperative outcomes; in particular, details on the mechanisms of malperfusion and organ(s) involved were entered into the model and tested. RESULTS: A total of 41 patients (60 years old [interquartile range (IQR): 51-68.5]; 78% men) have been included in the analysis. Patients were mostly (68.3%) affected by only 1 malperfusion syndrome, with renal ischemia being the most frequent (53.6%). The median length of aortic coverage was 197 mm (IQR: 157-209). Additional visceral/renal/iliac stentings were performed after stent graft implantation for 25 branches in 17 patients (41%). The 30-day mortality rate was 17.1%. All but 2 early deaths were related to malperfusion. The number of malperfusion syndromes was the only independent factor associated to increasing 30-day malperfusion-related complications or deaths (3 vs 1, HR = 30.3 [P = 0.001]; 3 vs 2, HR = 9.9 [P = 0.004]). CONCLUSIONS: Prognosis of patients with acute type B AoD complicated initially with malperfusion syndrome(s) is severe, especially if several territories are ischemic. Early identification of those complications can be lifesaving but still lacks hard criteria.
引用
- Sobocinski J, Delloye M, Hongku K, et al. Malperfusions in Acute Type B Aortic Dissection-Predictors of Outcomes. Ann Vasc Surg. 2019. PMID: 31034950. doi:10.1016/j.avsg.2019.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。